antibody-mediated rejection

Advertisement

cGxPJobs Banner

AstraZeneca and Daiichi Sankyo Secure FDA Approval for Enhertu in Early HER2 Breast Cancer

WILMINGTON, Del., May 15, 2026 AstraZeneca and Daiichi Sankyo have announced that the U.S. Food and Drug Administration (FDA)...

By cGxPwire Editor
May 20, 2026

Read More

SERB and Hansa Biopharma Strengthen Rare Disease Portfolio With Idefirix Agreement

BRUSSELS, Belgium, May 19, 2026 SERB Pharmaceuticals and Hansa Biopharma have announced a strategic €115 million licensing agreement granting...

By cGxPwire Editor
May 20, 2026

Read More

Advertisement

cGxPJobs

Directory